---
title: "SMITH LILLIAN — Ownership Dossier"
canonical: https://whiteintel.dev/entity/b245c1a0-e163-5d54-ae84-9432cccdc793
json: https://whiteintel.dev/api/public/dossier/b245c1a0-e163-5d54-ae84-9432cccdc793
identifier: sec:0001971448
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SMITH LILLIAN

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001971448`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/b245c1a0-e163-5d54-ae84-9432cccdc793  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/b245c1a0-e163-5d54-ae84-9432cccdc793  

## Ownership & control

### Holdings / subsidiaries

- **Allogene Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/4e083400-6ddd-5a48-a731-3eb4d4de5681

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SMITH LILLIAN**. Human view: https://whiteintel.dev/entity/b245c1a0-e163-5d54-ae84-9432cccdc793 · Structured JSON: https://whiteintel.dev/api/public/dossier/b245c1a0-e163-5d54-ae84-9432cccdc793._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._